288 related articles for article (PubMed ID: 19757056)
1. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
Neal RE; Davalos RV
Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation.
Shafiee H; Garcia PA; Davalos RV
J Biomech Eng; 2009 Jul; 131(7):074509. PubMed ID: 19640145
[TBL] [Abstract][Full Text] [Related]
4. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models.
Neal RE; Garcia PA; Kavnoudias H; Rosenfeldt F; Mclean CA; Earl V; Bergman J; Davalos RV; Thomson KR
IEEE Trans Biomed Eng; 2015 Feb; 62(2):561-9. PubMed ID: 25265626
[TBL] [Abstract][Full Text] [Related]
5. In vivo results of a new focal tissue ablation technique: irreversible electroporation.
Edd JF; Horowitz L; Davalos RV; Mir LM; Rubinsky B
IEEE Trans Biomed Eng; 2006 Jul; 53(7):1409-15. PubMed ID: 16830945
[TBL] [Abstract][Full Text] [Related]
6. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
Davalos RV; Bhonsle S; Neal RE
Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
[TBL] [Abstract][Full Text] [Related]
7. Electrical conductivity changes during irreversible electroporation treatment of brain cancer.
Garcia PA; Rossmeisl JH; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():739-42. PubMed ID: 22254416
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
10. Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues.
Daniels C; Rubinsky B
J Biomech Eng; 2009 Jul; 131(7):071006. PubMed ID: 19640131
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.
Olweny EO; Kapur P; Tan YK; Park SK; Adibi M; Cadeddu JA
Urology; 2013 Mar; 81(3):679-84. PubMed ID: 23290141
[TBL] [Abstract][Full Text] [Related]
12. A statistical model for multidimensional irreversible electroporation cell death in tissue.
Golberg A; Rubinsky B
Biomed Eng Online; 2010 Feb; 9():13. PubMed ID: 20187951
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation ablation: is all the damage nonthermal?
Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of irreversible electroporation for intracranial surgery.
Garcia PA; Rossmeisl JH; Robertson J; Ellis TL; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():6513-6. PubMed ID: 19964170
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Characterization of Parameters Affecting High-Frequency Irreversible Electroporation Lesions.
Miklovic T; Latouche EL; DeWitt MR; Davalos RV; Sano MB
Ann Biomed Eng; 2017 Nov; 45(11):2524-2534. PubMed ID: 28721494
[TBL] [Abstract][Full Text] [Related]
16. Introduction to Irreversible Electroporation--Principles and Techniques.
Thomson KR; Kavnoudias H; Neal RE
Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
[TBL] [Abstract][Full Text] [Related]
17. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
18. Optimal parameters for the destruction of prostate cancer using irreversible electroporation.
Rubinsky J; Onik G; Mikus P; Rubinsky B
J Urol; 2008 Dec; 180(6):2668-74. PubMed ID: 18951581
[TBL] [Abstract][Full Text] [Related]
19. Tissue ablation with irreversible electroporation.
Davalos RV; Mir IL; Rubinsky B
Ann Biomed Eng; 2005 Feb; 33(2):223-31. PubMed ID: 15771276
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation: a new ablation modality--clinical implications.
Rubinsky B; Onik G; Mikus P
Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
